Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Chronic Lymphocytic Leukemia. Show all posts
Showing posts with label Chronic Lymphocytic Leukemia. Show all posts
Saturday, February 9, 2019

FDA Approves Imbruvica (ibrutinib) Plus Obinutuzumab as First Non-Chemotherapy Combination Regimen for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia

›
In continuation of my update on    ibrutinib The Janssen Pharmaceutical Companies of Johnson & Johnson announced  the U.S. Foo...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.